[Medical treatment of epitheliomas].
Revenga Arranz
F
F
Unidad de Dermatología, Hospital Universitario Infanta Cristina, Badajoz.
D000368:Aged; D000369:Aged, 80 and over; D000622:Aminolevulinic Acid / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001913:Bowen's Disease / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D002277:Carcinoma / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*; D002280:Basal Cell Carcinoma / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage; D007372:Interferons / Q000008:administration & dosage; D015474:Isotretinoin / Q000627:therapeutic use; D007641:Keratolytic Agents / Q000627:therapeutic use; D008297:Male; D009362:Neoplasm Metastasis; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D012176:Retinoids / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*
D000970:Antineoplastic Agents; D016898:Interferon-alpha; D007641:Keratolytic Agents; D017319:Photosensitizing Agents; D012176:Retinoids; D000622:Aminolevulinic Acid; D007372:Interferons; D015474:Isotretinoin
Tratamiento médico de los epiteliomas.